biotech · Choroideremia · X-Linked Retinitis Pigmentosa · FDMT
4D Molecular Therapeutics
4D Molecular Therapeutics patent portfolio — 15 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 5858 Horton St, 455, Emeryville, California 94608, US
- Founded
- 2013
- Employees
- 213
- Programs
- 19
- Drugs
- 13
- Patents
- 15
4D Molecular Therapeutics patents
15 pharmaceutical patents indexed for 4D Molecular Therapeutics. 0 expire within 24 months.
4D Molecular Therapeutics has 15 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11840704
Adeno-associated virus variant capsids and methods of use thereof
granted -
US 11807868
Adeno-associated variants, formulations and methods for pulmonary delivery
granted -
US 11766489
Adeno-associated virus variant capsids and use for inhibiting angiogenesis
granted -
US 11766487
Treatments for retinal disease
granted -
US 11576983
Treatments for retinal disease
granted -
US 11524081
Codon optimized REP1 genes and uses thereof
granted -
US 11499166
Adeno-associated variants, formulations and methods for pulmonary delivery
granted -
US 11419949
Adeno-associated virus variant capsids and methods of use thereof
granted -
US 11364308
Adeno-associated virus variant capsids and methods of use thereof
granted -
US 11357870
Codon optimized REP1 genes and uses thereof
granted -
US 11345930
Codon optimized RPGRORF15 genes and uses thereof
granted -
US 11198858
Codon optimized GLA genes and uses thereof
granted -
US 11179477
Method of using adeno-associated virus with variant capsid
granted -
US 11167041
Adeno-associated virus variant capsids and methods of use thereof
granted -
US 11118192
Adeno-associated virus variant capsids and methods of use thereof
granted
Frequently asked questions
How many patents does 4D Molecular Therapeutics have?
15 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do 4D Molecular Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.